Q2 and H1 FY26 results filed; revenue declined sharply YoY

Revenue DeclineResults View source PDF Explain this filing

URAVIDEF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.9%Reaction day

₹224.99

prior close

₹222.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-3.6% vs market

Auto Components & Equipments peers, median of 109sector+0.4%-4.3% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 4.3 pts less than its Auto Components & Equipments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-0.9

15m

-1.8

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.9-0.3-3.6+0.4-4.3

Next day

-0.9+0.7-1.6+1.0-1.9

-2.7+0.6-3.2+0.6-3.2

-1.8+0.5-2.3+0.7-2.4

-3.6+1.1-4.6+0.4-4.0

-9.7+0.3-9.9-0.2-9.5

-10.9-0.2-10.7-0.5-10.3

15d

-18.6-2.2-16.4-1.6-17.0

-27.1-4.9-22.2-3.1-24.0

-12.7-7.5-5.2-7.2-5.4

-20.6-4.8-15.9-3.9-16.7

UpDownMarket · Nifty Microcap 250Sector · Auto Components & Equipments peers, median of 109Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Uravi Defence filed Q2 and H1 FY26 unaudited results. Standalone Q2 revenue fell to about Rs 10.2 crore from Rs 18.6 crore YoY, a 45 percent drop. Consolidated H1 revenue fell to about Rs 22.1 crore from Rs 32.1 crore. PAT was marginal. Subsidiary Bharat Technology bought 19.80 percent in UK firm Spafax International for about Rs 8.73 crore as part of a multi-tranche deal for up to 100 percent. Unmodified limited review.

Likely market impact

Sharp YoY revenue drop with thin profit margins; UK acquisition adds growth bet but near-term execution risk.